Post Profile






Cardiac Risk a Factor When Considering Hormonal Therapy for Prostate Cancer

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack.
read more

share
See more about: Prostate Cancer

Related Posts


New Study Reassures on Heart Risks of Prostate Cancer Treatment

Health : Newswise Medical News

Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women's Cancer Center.

NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy

Health : Newswise Medical News

Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early resu...

Hormone Deprivation Therapy for Prostate Cancer May Raise Diabetes Risk

Health : Newswise Medical News

Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cance...

Men At 'High' Skeletal Risk Prior To Prostate Cancer Hormone Therapy Likely To Have More Fractures After Treatment

Health : Medical News Today

Comprehensive Population-Based Study Conducted by Team at The Cancer Institute of New Jersey In what is believed to be the first study to describe the impact on men with a 'high' risk of bone fracture who are receiving long-term and...

Men at 'High' Skeletal Risk Prior to Prostate Cancer Hormone Therapy Likely to Have More Fractures After Treatment

Health : Newswise Medical News

In what is believed to be the first study to describe the impact on men with a 'high' risk of bone fracture who are receiving long-term androgen deprivation therapy (ADT) for prostate cancer, new research from The Cancer Institute o...

Comments


Copyright © 2016 Regator, LLC